Traumatic intraventricular hemorrhage treated with intraventricular recombinant-tissue plasminogen activator: Technical case report

被引:21
|
作者
Grabb, PA [1 ]
机构
[1] Univ Alabama, Childrens Hosp, Div Neurosurg, Tuscaloosa, AL 35487 USA
关键词
brain injury; hydrocephalus; intraventricular hemorrhage; thrombolysis;
D O I
10.1097/00006123-199810000-00150
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE AND IMPORTANCE: Traumatic intraventricular hemorrhage (IVH) can result in association with acute obstructive hydrocephalus, repetitive malfunction of external ventricular drains (EVDs), and uncontrollable increased intracranial pressure. We report a case showing the safe and effective use of intraventricular recombinant-tissue plasminogen activator in a child with severe brain injury and acute hydrocephalus from IVH. CLINICAL PRESENTATION: A 15-year-old male patient presented to us after a motor vehicle accident with bilateral extensor posturing, intracerebral and IVH, and acute obstructive hydrocephalus. INTERVENTION: A right EVD was placed and functioned only transiently. A left EVD was placed and functioned only transiently. Because of the inability to maintain ventricular drainage, rising intracranial pressure, and worsening clinical status, 5 mg of recombinant-tissue plasminogen activator was injected through each EVD. Excellent EVD function was obtained quickly, with control of intracranial pressure and improvement in clinical status and without hemorrhagic complication. CONCLUSION: With obstructive hydrocephalus secondary to acute traumatic IVH that cannot be controlled with EVD because of recurrent obstruction from intraventricular blood, intraventricular recombinant-tissue plasminogen activator can be effective and safe, despite preexisting multiple hemorrhagic intracranial injuries.
引用
收藏
页码:966 / 969
页数:4
相关论文
共 50 条
  • [21] Intraventricular Tissue Plasminogen Activator and Shunt Dependency in Aneurysmal Subarachnoid Hemorrhage Patients With Cast Ventricles
    Catapano, Joshua S.
    Rumalla, Kavelin
    Karahalios, Katherine
    Srinivasan, Visish M.
    Labib, Mohamed A.
    Cole, Tyler S.
    Baranoski, Jacob F.
    Rutledge, Caleb
    Rahmani, Redi
    Jadhav, Ashutosh P.
    Ducruet, Andrew F.
    Albuquerque, Felipe C.
    Zabramski, Joseph M.
    Lawton, Michael T.
    NEUROSURGERY, 2021, 89 (06) : 973 - 977
  • [22] Low-Dose Recombinant Tissue-Type Plasminogen Activator Enhances Clot Resolution in Brain Hemorrhage The Intraventricular Hemorrhage Thrombolysis Trial
    Naff, Neal
    Williams, Michael A.
    Keyl, Penelope M.
    Tuhrim, Stanley
    Bullock, M. Ross
    Mayer, Stephan A.
    Coplin, William
    Narayan, Raj
    Haines, Stephen
    Cruz-Flores, Salvador
    Zuccarello, Mario
    Brock, David
    Awad, Issam
    Ziai, Wendy C.
    Marmarou, Anthony
    Rhoney, Denise
    McBee, Nichol
    Lane, Karen
    Hanley, Daniel F.
    STROKE, 2011, 42 (11) : 3009 - 3016
  • [23] Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage
    Ionita, CC
    Ferrara, J
    McDonagh, DL
    Grassi, P
    Graffagnino, C
    NEUROCRITICAL CARE, 2005, 3 (03) : 246 - 248
  • [24] Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage
    Catalina C. Ionita
    Joseph Ferrara
    David L. McDonagh
    Peter Grossi
    Carmelo Graffagnino
    Neurocritical Care, 2005, 3 : 246 - 248
  • [25] Intraventricular Tissue Plasminogen Activator in Subarachnoid Hemorrhage Patients: A Prospective, Randomized, Placebo-Controlled Pilot Trial
    Kramer, Andreas H.
    Roberts, Derek J.
    Holodinsky, Jessalyn
    Todd, Stephanie
    Hill, Michael D.
    Zygun, David A.
    Faris, Peter
    Wong, John H.
    NEUROCRITICAL CARE, 2014, 21 (02) : 275 - 284
  • [26] Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus
    Whitelaw, A
    Saliba, E
    Fellman, V
    Mowinckel, MC
    Acolet, D
    Marlow, N
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1996, 75 (01): : F20 - F26
  • [27] Comparative efficacy of urokinase and recombinant tissue-type plasminogen activators in intraventricular hemorrhage
    Kiyoon Yang
    Kyung Hwan Kim
    Heewon Jeong
    Eun-Oh Jeong
    Han-Joo Lee
    Hyon-Jo Kwon
    Seung-Won Choi
    Seon-Hwan Kim
    Hyeon-Song Koh
    Neurosurgical Review, 48 (1)
  • [28] Idiopathic Intraventricular Aneurysm Presenting with Intraventricular Hemorrhage: Case Report and Review of the Literature
    Madhugiri, Venkatesh S.
    Gundamaneni, Sudheer Kumar
    Yadav, Awdhesh Kumar
    Sasidharan, Gopalakrishnan M.
    Roopesh, Kumar V. R.
    PEDIATRIC NEUROSURGERY, 2012, 48 (03) : 174 - 180
  • [29] Intraventricular Tissue Plasminogen Activator in Subarachnoid Hemorrhage Patients: A Prospective, Randomized, Placebo-Controlled Pilot Trial
    Andreas H. Kramer
    Derek J. Roberts
    Jessalyn Holodinsky
    Stephanie Todd
    Michael D. Hill
    David A. Zygun
    Peter Faris
    John H. Wong
    Neurocritical Care, 2014, 21 : 275 - 284
  • [30] Using low-dose tissue plasminogen activator through external ventricular drain and Cerebrolysin for the treatment of severe intraventricular hemorrhage: A case report
    Hoang Ngoc, Nguyen
    Van Tuyen, Nguyen
    SAGE OPEN MEDICAL CASE REPORTS, 2020, 8